Amanote Research
Register
Sign In
Role of Intracellular Tyrosines in Activating KIT-induced Myeloproliferative Disease
Leukemia
- United Kingdom
doi 10.1038/leu.2012.22
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
February 2, 2012
Authors
P Ma
R S Mali
H Martin
B Ramdas
E Sims
R Kapur
Publisher
Springer Science and Business Media LLC
Related search
Acute Myeloproliferative Disease
Intracellular Growth Factors in Polycythemia Vera and Other Myeloproliferative Disorders.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
IL-3 Receptor Signaling Is Dispensable for BCR-ABL-induced Myeloproliferative Disease
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Pulmonary Veno-Occlusive Disease in Myeloproliferative Disorder
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Activating FLT3 Mutations in CD117/KIT+ T-Cell Acute Lymphoblastic Leukemias
Blood
Biochemistry
Immunology
Cell Biology
Hematology
The Role of Intracellular Protein O-Glycosylation in Cell Adhesion and Disease
Journal of Biomedical Research
Biochemistry
Medicine
Genetics
Molecular Biology
Role of Oxygen Derived Free Radicals in Platelet Activating Factor Induced Bowel Necrosis.
Gut
Gastroenterology
Adoptive Immunotherapy of BCR-ABL-induced Chronic Myeloid Leukemia-Like Myeloproliferative Disease in a Murine Model
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Molecular Drug Targets in Myeloproliferative Neoplasms: Mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology